Loading...
XSHE
300049
Market cap1.62bUSD
Jul 10, Last price  
43.25CNY
1D
3.87%
1Q
-24.63%
Jan 2017
106.44%
IPO
333.37%
Name

Inner Mongolia Furui Medical Science Co Ltd

Chart & Performance

D1W1MN
XSHE:300049 chart
P/E
74.10
P/S
7.17
EPS
0.58
Div Yield, %
Shrs. gr., 5y
0.52%
Rev. gr., 5y
14.55%
Revenues
1.59b
+18.07%
121,590,130126,413,281141,257,489179,975,339210,246,377301,658,211407,639,040523,483,187645,517,668604,191,264826,987,166823,331,334867,029,327831,739,342807,532,607898,483,2281,008,765,8611,153,733,8861,349,015,1801,592,829,219
Net income
154m
+36.02%
22,608,68522,476,59925,816,98434,418,07446,853,13852,490,69641,137,5394,905,38887,235,29891,685,246121,047,93361,114,10635,416,10443,385,85461,905,64695,468,88197,889,814101,563,744113,285,457154,089,068
CFO
354m
+59.95%
49,515,95717,846,52336,473,049-2,095,88049,198,38275,751,89285,883,73228,183,17150,875,669158,159,638148,843,876131,720,83478,347,686256,227,191200,151,631222,552,216189,461,778304,889,062221,408,410354,149,132
Dividend
Jun 13, 20230.2 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Inner Mongolia Furui Medical Science Co., Ltd. functions as a dedicated platform offering specialized healthcare services. The company's primary focus lies in the liver disease sector, where it delivers a full spectrum of solutions encompassing accurate disease diagnosis, pharmaceutical treatments, and ongoing chronic condition management. Beyond this, it also provides comprehensive health management facilities and general medical care services. Established in 1998, with its headquarters situated in Beijing, China, the entity was previously known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company.
IPO date
Jan 20, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT